首页> 外文期刊>Biomaterials >Bi-layered polyurethane - Extracellular matrix cardiac patch improves ischemic ventricular wall remodeling in a rat model
【24h】

Bi-layered polyurethane - Extracellular matrix cardiac patch improves ischemic ventricular wall remodeling in a rat model

机译:双层聚氨酯 - 细胞外基质心脏贴片改善了大鼠模型中的缺血性心室壁改造

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

As an intervention to abrogate ischemic cardiomyopathy, the concept of applying a temporary, local patch to the surface of the recently infarcted ventricle has been explored from a number of design perspectives. Two important features considered for such a cardiac patch include the provision of appropriate mechanical support and the capacity to influence the remodeling pathway by providing cellular or biomolecule delivery. The objective of this report was to focus on these two features by first evaluating the incorporation of a cardiac extracellular matrix (ECM) component, and second by evaluating the impact of patch anisotropy on the pathological remodeling process initiated by myocardial infarction. The functional outcomes of microfibrous, elastomeric, biodegradable cardiac patches have been evaluated in a rat chronic infarction model. Ten weeks after infarction and 8 wk after patch epicardial placement, echocardiographic function, tissue-level structural remodeling (e.g., biaxial mechanical response and microstructural analysis), and cellular level remodeling were assessed. The results showed that the incorporation of a cardiac ECM altered the progression of several keys aspects of maladaptive remodeling following myocardial infarction. This included decreasing LV global mechanical compliance, inhibiting echocardiographically-measured functional deterioration, mitigating scar formation and LV wall thinning, and promoting angiogenesis. In evaluating the impact of patch anisotropy, no effects from the altered patch mechanics were detected after 8 wk, possibly due to patch fibrous encapsulation. Overall, this study demonstrates the benefit of a cardiac patch design that combines both ventricle mechanical support, through a biodegradable, fibrillary elastomeric component, and the incorporation of ECM-based hydrogel components. (C) 2016 Elsevier Ltd. All rights reserved.
机译:作为废除缺血性心肌病的干预,从许多设计视角探讨了将临时局部贴剂应用于最近梗死的心室表面的概念。考虑这种心脏贴剂的两个重要特征包括通过提供细胞或生物分子递送来提供适当的机械支撑和影响重塑途径的能力。本报告的目的是首先通过首先通过评估掺入心脏细胞外基质(ECM)组分的掺入,并通过评估斑块各向异性对心肌梗塞引发的病理重塑过程的影响来评估这两个特征。在大鼠慢性梗死模型中已经评估了微纤维,弹性体,可生物降解的心脏贴片的功能蛋白。梗死后十周和膜外形放置后8周,超声心动图函数,组织级结构重塑(例如,双轴机械响应和微观结构分析)和细胞水平重塑。结果表明,心脏病ECM的掺入改变了心肌梗死后不良后重塑的几个键方面的进展。这包括降低LV全球机械顺应性,抑制超声心动图测量的功能性劣化,缓解瘢痕形成和LV壁稀释,以及促进血管生成。在评估斑块各向异性的影响时,在8周后没有从改变的贴片机制的影响,可能是由于贴片纤维封装。总体而言,本研究表明,心脏贴片设计的益处,其通过可生物降解,纤维弹性体组分和掺入ECM的水凝胶组分结合的心脏贴片设计。 (c)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号